Alpha 2.0
Login Register
» Authors » Chamila Mettananda

Chamila Mettananda

Explore the profile of Chamila Mettananda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 82
Followers 0
Related Specialties
General Medicine
Science
Oncology
Top 10 Co-Authors
Sachith Mettananda
Anuja Premawardhena
Ravindu Peiris
Arunasalam Pathmeswaran
Udaya de Silva
Nethmi Wickramarathne
Dayananda Bandara
Hashan Pathiraja
Nathasha Luke
Anuradha Supun Dassanayake
Published In
BMJ Open
PLoS One
Sci Rep
BMJ Case Rep
Pediatr Blood Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Multimorbidity, medications, and their association with falls, physical activity, and cognitive functions in older adults: multicenter study in Sri Lanka
De Zoysa W, Mendis S, Rathnayake N, Liyanage A, Palangasinghe D, Silva S, et al.
Sci Rep . 2025 Feb; 15(1):6233. PMID: 39979482
This study was aimed to examine the prevalence and associations between multimorbidity, polypharmacy, Falls Risk Increasing Drugs use (FRIDs), Anti Cholinergic Burden (ACB), and adverse health outcomes in older adults...
2.
Comparison of cardiovascular risk prediction models developed using machine learning based on data from a Sri Lankan cohort with World Health Organization risk charts for predicting cardiovascular risk among Sri Lankans: a cohort study
Mettananda C, Solangaarachchige M, Haddela P, Dassanayake A, Kasturiratne A, Wickremasinghe R, et al.
BMJ Open . 2025 Jan; 15(1):e081434. PMID: 39819943
Introduction: Models derived from non-Sri Lankan cohorts are used for cardiovascular (CV) risk stratification of Sri Lankans. Objective: To develop a CV risk prediction model using machine learning (ML) based...
3.
Undetected falls among older adults attending medical clinics in four tertiary care centres in Sri Lanka; the need of a comprehensive geriatric assessment
De Zoysa W, Rathnayake N, Palangasinghe D, Silva S, Jayasekera P, Mettananda C, et al.
BMC Geriatr . 2024 Oct; 24(1):864. PMID: 39443852
Objective: Falls take a high priority among the prevalent medical conditions in old age. Despite this, a history of falls or the risk of future falls is not routinely assessed...
4.
Development and validation of a cardiovascular risk prediction model for Sri Lankans using machine learning
Mettananda C, Sanjeewa I, Benthota Arachchi T, Wijesooriya A, Chandrasena C, Weerasinghe T, et al.
PLoS One . 2024 Oct; 19(10):e0309843. PMID: 39436892
Introduction And Objectives: Sri Lankans do not have a specific cardiovascular (CV) risk prediction model and therefore, World Health Organization(WHO) risk charts developed for the Southeast Asia Region are being...
5.
Persistent, Poorly Responsive Immune Thrombocytopenia Secondary to Asymptomatic COVID-19 Infection in a Child
Mettananda C, Williams S
Case Rep Infect Dis . 2023 Dec; 2023:3298520. PMID: 38145004
Immune thrombocytopenic purpura (ITP) secondary to asymptomatic COVID-19 infection, especially in children, is not reported. Furthermore, persistent, treatment-resistant ITP secondary to COVID-19 is not reported. We report a previously healthy...
6.
Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka
Mettananda C, Peiris C, Abeyrathna D, Gunasekara A, Egodage T, Dantanarayana C, et al.
BMJ Open . 2023 Dec; 13(12):e075803. PMID: 38101843
Objectives: To study if early initiation of inhaled beclomethasone 1200 mcg in patients with asymptomatic, mild or moderate COVID-19 reduces disease progression to severe COVID-19. Design: Double-blinded, parallel-groups, randomised, placebo-controlled...
7.
Glycaemic control and avenues for improvement among people with type 2 diabetes mellitus from rural Sri Lanka - a retrospective cohort study
Mettananda C, Chathuranga U, Rathnayake T, Luke N, Meegodavidanage N
Lancet Reg Health Southeast Asia . 2023 Jun; 12:100169. PMID: 37384066
Background: The majority of Sri Lankans and South Asians are rural dwellers but follow-up data on glycaemic control and its associations in rural communities are sparse. We followed up a...
8.
Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study
Mettananda C, Egodage T, Dantanarayana C, Fernando R, Ranaweera L, Luke N, et al.
BMJ Open . 2023 Jan; 13(1):e063959. PMID: 36639212
Introduction: Identification of advanced hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD) is important as this may progress to cirrhosis and hepatocellular carcinoma. The risk of hepatic fibrosis is especially...
9.
Sequential occurrence of recurrent Sweet syndrome and erythema nodosum without an underlying secondary cause: a case report
Mettananda C, Peiris H, Uwyse A
J Med Case Rep . 2022 Feb; 16(1):82. PMID: 35209933
Background: Sweet syndrome is a rare cause of acute fever and painful erythematous skin plaques. Erythema nodosum is acute or chronic tender erythematous skin nodules of bilateral shins. The concurrent...
10.
A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, et al.
Sci Rep . 2022 Feb; 12(1):2752. PMID: 35177777
Hydroxyurea is an antimetabolite drug that induces fetal haemoglobin in sickle cell disease. However, its clinical usefulness in β-thalassaemia is unproven. We conducted a randomised, double-blind, placebo-controlled clinical trial to...